Epizyme, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Report date

6/30/2022

Quarter

2022 Q2

Filed

8/15/2022

Shares

686,966

Value ($000)

1,010

Weight

0.0%

2013 Q4 - 2022 Q2 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q2	8/15/2022	1,010	0.0%	686,966	6/30/2022
2022 Q1	5/13/2022	1,175	0.0%	1,021,113	3/31/2022
2021 Q4	2/11/2022	1,594	0.0%	637,481	12/31/2021
2021 Q3	11/16/2021	3,221	0.0%	629,078	9/30/2021
2021 Q2	8/16/2021	5,289	0.0%	636,398	6/30/2021
2021 Q1	5/17/2021	5,459	0.0%	626,692	3/31/2021
2020 Q4	2/16/2021	6,600	0.0%	607,660	12/31/2020
2020 Q3	11/13/2020	7,208	0.0%	604,142	9/30/2020
2020 Q2	8/20/2020	8,696	0.0%	541,416	6/30/2020
2020 Q1	5/15/2020	7,452	0.0%	480,454	3/31/2020
2019 Q4	2/7/2020	11,537	0.0%	468,945	12/31/2019
2014 Q2	7/30/2014	861	0.0%	27,655	6/30/2014
2014 Q1	4/29/2014	397	0.0%	17,431	3/31/2014
2013 Q4	2/14/2014	267	0.0%	12,826	12/31/2013